A
Alexandre Gomes Vizzoni
Researcher at Oswaldo Cruz Foundation
Publications - 17
Citations - 557
Alexandre Gomes Vizzoni is an academic researcher from Oswaldo Cruz Foundation. The author has contributed to research in topics: Dengue virus & Medicine. The author has an hindex of 7, co-authored 12 publications receiving 329 citations.
Papers
More filters
Journal ArticleDOI
Rapid antigen tests for dengue virus serotypes and Zika virus in patient serum
Irene Bosch,Irene Bosch,Helena de Puig,Megan Hiley,Marc Carré-Camps,Federico Perdomo-Celis,Carlos F. Narváez,Doris M. Salgado,Dewahar Senthoor,Madeline O’Grady,Elizabeth J. Phillips,Ann Durbin,Ann Durbin,Diana Fandos,Hikaru Miyazaki,Chun-Wan Yen,Margarita Gélvez-Ramírez,Rajas V. Warke,Lucas S. Ribeiro,Mauro M. Teixeira,Roque P. Almeida,José Esteban Muñoz-Medina,Juan E. Ludert,Maurício Lacerda Nogueira,Tatiana Elias Colombo,Ana Carolina Bernardes Terzian,Patrícia T. Bozza,Andrea Surrage Calheiros,Yasmine Rangel Vieira,Giselle Barbosa-Lima,Alexandre Gomes Vizzoni,José Cerbino-Neto,Fernando A. Bozza,Thiago Moreno L. Souza,Monique R.O. Trugilho,Ana Maria Bispo de Filippis,Patrícia Carvalho de Sequeira,Ernesto T. A. Marques,Ernesto T. A. Marques,Tereza Magalhaes,Tereza Magalhaes,Francisco J. Díaz,Berta Nelly Restrepo,Katerine Marín,Salim Mattar,Daniel G. Olson,Edwin J. Asturias,Mark Lucera,Mohit Singla,Guruprasad R. Medigeshi,Norma de Bosch,Justina O. Tam,Jose Gomez-Marquez,Charles R. Clavet,Luis Angel Villar,Kimberly Hamad-Schifferli,Kimberly Hamad-Schifferli,Lee Gehrke,Lee Gehrke +58 more
TL;DR: The characterization of monoclonal antibody pairs that have been translated into rapid immunochromatography tests to specifically detect the viral nonstructural 1 (NS1) protein antigen and distinguish the four DENV serotypes (DENV1–4) and ZIKV without cross-reaction are reported.
Journal ArticleDOI
A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19.
Max R. O'Donnell,Beatriz Grinsztejn,Matthew J. Cummings,Jessica Justman,Matthew R. Lamb,Christina M. Eckhardt,Neena M. Philip,Ying Kuen Cheung,Vinay Gupta,Esau Joao,José Henrique Pilotto,Maria Pia Diniz,Sandra W. Cardoso,Darryl Abrams,Kartik N. Rajagopalan,Sarah Borden,Allison Wolf,Leon Claude Sidi,Alexandre Gomes Vizzoni,Valdilea G. Veloso,Zachary C. Bitan,Dawn E. Scotto,Benjamin J. Meyer,Samuel D. Jacobson,Alex Kantor,Nischay Mishra,Lokendra V. Chauhan,Elizabeth F. Stone,Flavia Dei Zotti,Francesca La Carpia,Krystalyn E. Hudson,Stephen A. Ferrara,Joseph E. Schwartz,Brie A. Stotler,Wen-Hsuan W. Lin,Sandeep N. Wontakal,Beth H. Shaz,Thomas Briese,Eldad A. Hod,Steven L. Spitalnik,Andrew Eisenberger,Walter Ian Lipkin +41 more
TL;DR: In a randomized, double-blind, controlled trial among adults hospitalized with severe and critical COVID-19 at 5 sites in New York City (USA) and Rio de Janeiro (Brazil), patients were randomized 2:1 to receive either convalescent plasma or normal control plasma as discussed by the authors.
Posted ContentDOI
A randomized, double-blind, controlled trial of convalescent plasma in adults with severe COVID-19
Max R. O'Donnell,Beatriz Grinsztejn,Matthew J. Cummings,Jessica Justman,Matt Lamb,Christina M. Eckhardt,Neena Phillip,Kenneth Cheung,Darryl Abrams,Vinay Gupta,Maria Pia Diniz,Sandra W. Cardoso,Kartik N. Rajagopalan,Sarah Borden,Allison Wolf,Zachary C. Bitan,Benjamin J. Meyer,Samuel G. Jacobson,Alex Kantor,Nischay Mishra,Eldad A. Hod,Thomas Briese,Leon Claude Sidi,Sandeep N. Wontakal,Krystalyn E. Hudson,Brie A. Stotler,Wen-Hsuan W. Lin,José Henrique Pilotto,Esau Joao,Lokendra V. Chauhan,Valdilea G. Veloso,Joseph E. Schwartz,Elizabeth F. Stone,Flavia Dei Zotti,Francesca La Carpia,Beth H. Shaz,Stephen A. Ferrara,Alexandre Gomes Vizzoni,Steven Spitalnick,Andrew Eisenberger,W. Ian Lipin +40 more
TL;DR: In this paper, the clinical efficacy and safety of convalescent plasma among adults hospitalized with severe and critical COVID-19 was evaluated in a randomized controlled trial conducted from April 21st to November 27th, 2020.
Journal ArticleDOI
Clinical Manifestations of Zika Virus Infection, Rio de Janeiro, Brazil, 2015.
José Cerbino-Neto,Emersom Cicilini Mesquita,Thiago Moreno L. Souza,Viviane Parreira,Bernardo Bastos Wittlin,Betina Durovni,Maria Cristina Ferreira Lemos,Alexandre Gomes Vizzoni,Ana Maria Bispo de Filippis,Simone Alves Sampaio,Bianca de Santis Gonçalves,Fernando A. Bozza +11 more
TL;DR: The frequency of signs and symptoms from a sample of clinic patients in Rio de Janeiro, Brazil, who were later confirmed to have Zika virus disease by using real-time reverse transcription PCR (rRT-PCR), found rash to be the most common symptom for which patients sought care.
Journal ArticleDOI
Emergence of the East-Central-South-African genotype of Chikungunya virus in Brazil and the city of Rio de Janeiro may have occurred years before surveillance detection
Thiago Moreno L. Souza,Yasmine Rangel Vieira,Edson Delatorre,Giselle Barbosa-Lima,Raul Leal Faria Luiz,Alexandre Gomes Vizzoni,Komal Jain,Milene Mesquita,Nishit Bhuva,Jan F. Gogarten,Jan F. Gogarten,Jan F. Gogarten,James Ng,Riddhi Thakkar,Andrea Surrage Calheiros,Ana Paula T. Monteiro,Patrícia T. Bozza,Fernando A. Bozza,Diogo A. Tschoeke,Luciana Leomil,Marcos Cesar Lima de Mendonça,Cintia Damasceno dos Santos Rodrigues,Maria C. Torres,Ana Maria Bispo de Filippis,Rita Maria Ribeiro Nogueira,Fabiano L. Thompson,Fabiano L. Thompson,Cristina Lemos,Betina Durovni,José Cerbino-Neto,Carlos M. Morel,W. Ian Lipkin,Nischay Mishra +32 more
TL;DR: The observation that the ECSA genotype of CHIKV was circulating undetected underscores the need for improvements in molecular methods for viral surveillance.